TJX Companies

TJX Companies reported Q2 fiscal 2027 sales of $15.18 billion, consolidated comparable sales up 4% and adjusted EPS up 11%, and raised its full-year EPS outlook. Weakness was concentrated in Marmaxx (TJ Maxx, Marshalls, Sierra), where comparable sales rose just 1% as management cited store‑mix execution issues it says are fixed but did not disclose specifics. Jim Cramer expressed concern over the unexplained stumble after Ross posted much stronger comp growth, warning the Marmaxx slowdown could persist and weigh on TJX stock if recovery takes longer than management expects. » Więcej na finance.yahoo.com

TJX stock reached a new 52-week low of $125.49, 26% below the year high of $170; it is down 9.66% over the past year and nearly 17% year-to-date. Technical indicators point to oversold conditions, and an InvestingPro fair-value calculation signals possible undervaluation. Operationally, TJX reported better-than-expected Q2 results (adjusted EPS $1.22, revenue $15.2bn, comparable-store sales +4%, adjusted pre-tax profit margin 11.9%), while concerns remain about a slowdown in the Marmaxx segment. Analyst reactions ranged from downgrades and price-target cuts to confirmations and raises, reflecting a mixed assessment of the company's prospects. » Więcej na de.investing.com

Crystal Temptations is recalling chocolate eyeball candy sold under its Crystal Temptations brand at Marshalls, TJ Maxx, HomeGoods and Sierra Trading Post after packaging failed to disclose milk, posing a risk of serious allergic reactions. The product was distributed in multiple states including Arizona, California, New Jersey and Texas. No illnesses have been reported; consumers are advised to destroy the candy and contact Crystal Temptations for a refund, while retailers will not issue returns. » Więcej na cbsnews.com